Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Genetic Testing Can Help the US Cut Costs and Improve Health Care

July 25, 2011 4:44 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, July 25, 2011 /PRNewswire-USNewswire/ -- Genetic testing made possible by the mapping of the human genome can help the US cut costs and create jobs while at the same time improving survival rates for such diseases as cancer, HIV, and heart disease. This according to Alan...

Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis

July 25, 2011 1:39 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, July 25, 2011 /- A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis (TB). Serological tests measure antibodies to TB in serum and are different to...

Children's Hospital, Genethon get FDA OK for gene therapy trial

July 22, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Children's Hospital Boston has won approval from the U.S. Food and Drug Administration for a gene therapy trial in conjunction with French biotech Genethon to treat the rare immunodeficiency known as Wiskott-Aldrich syndrome.


Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance

July 21, 2011 6:38 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., July 21, 2011 /- Quanterix Corporation, an in-vitro diagnostics (IVD) company providing life science researchers and IVD labs single molecule technology with unprecedented sensitivity and precision, announced that the analytical performance of AccuPSA™, a...

Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies

July 20, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

LAS VEGAS, July 20, 2011 /- Cardinal Health today announced that this week's Retail Business Conference (RBC), its annual, national trade show for independent pharmacies, is the largest in the event's 20+ year history, with nearly 7,000 attendees. This year's event, taking place July...

Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant

July 20, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, July 20, 2011 /- One of Frantz Medical Group's (FMG) subsidiaries, VasoStar Inc., Mentor, Ohio  today announced that it has been awarded an Ohio Third Frontier grant to further develop and commercialize a novel electromagnetic guidewire system for penetrating through...

CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results

July 20, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

ATLANTA, July 20, 2011 /- CryoLife, Inc. (NYSE: CRY ), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 second quarter financial results will be released on Thursday, July 28, 2011.  On that day, the Company...

Provent® Sleep Apnea Therapy Now Available in India

July 19, 2011 9:37 pm | by Bio-Medicine.Org | News | Comments

BELMONT, Calif. and HYDERABAD, India, July 20, 2011 /- Ventus Medical is pleased to announce the Indian launch of its proprietary Provent® Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea (OSA). Orbees Business Solutions Pvt. Ltd. will be the...


OrbusNeich's Genousâ„¢ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

July 18, 2011 10:51 am | by Bio-Medicine.Org | News | Comments

HONG KONG, July 18, 2011 /- Data from high-risk patients requiring early discontinuation of dual antiplatelet therapy (DAPT) due to nondeferrable, non-cardiac surgery show good short- and long-term clinical and safety outcomes following treatment with OrbusNeich's Genous Stent, according...

Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis

July 15, 2011 8:42 am | by Bio-Medicine.Org | News | Comments

EDISON, N.J., July 15, 2011 /- Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase. This group of drugs has had a...

Coriell Institute Teams With IBM to Advance Personalized Medicine

July 15, 2011 3:40 am | by Bio-Medicine.Org | News | Comments

ARMONK, N.Y. and CAMDEN, N.J., July 15, 2011 /- IBM (NYSE: IBM ) today announced that Coriell Institute for Medical Research, the largest biobank of living human cells, is using IBM technology to advance its research of human genetic disease and to more efficiently maintain its massive...

Top U.S. Hypertension Hot Spots Revealed

July 12, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

DEERFIELD, Ill., July 12, 2011 /- A national analysis conducted by Sperling's BestPlaces, sponsored by Takeda Pharmaceuticals North America, Inc., identifies the nation's Hypertension Hot Spots, or cities that face the most challenges due to hypertension risk factors and complications....

TandemHeart Approved for Expanded Reimbursement

July 12, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, July 12, 2011 /- The TandemHeart circulatory support system has been granted expanded reimbursement coverage by NHIC, Corp., the Medicare Administrative Contractor (MAC) serving over 1.3 million beneficiaries and over 53,000 healthcare providers in the Northeast region of the...


Topaz Pharmaceuticals' Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs

July 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa., July 11, 2011 /- In a study sponsored by Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, scientists from the University of Massachusetts, Amherst presented data showing that a 0.5% ivermectin (IVM) cream formulation was active against lice eggs...

Greenway Takes Leadership Role in Multiple Regional Extension Center Initiatives

July 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

CARROLLTON, Ga., July 11, 2011 /- Greenway Medical Technologies, Inc., provider of the integrated, single-database electronic health record (EHR), practice management and interoperability solution PrimeSUITE, has established industry leadership in the advancement and success of the...

Brockton Visiting Nurse Association Selects Cardiocom® Telehealth

July 11, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, July 11, 2011 /- Brockton Visiting Nurse Association, a 100 year old provider of home care services to the residents of Southeastern Massachusetts, announced that it has entered into a business relationship with Cardiocom to provide advanced home telehealth technology to...

Ascribe Listed Among Top Finalists for the 2011 Microsoft Public Sector – Health Partner of the Year Award

July 11, 2011 3:33 am | by RealWire | News | Comments

Bolton, UK — July 11th, 2011 — Today, Ascribe announced it has been selected as a finalist for the Microsoft Public Sector - Health Partner of the Year Award. "Ascribe is delighted to be recognised for our continuing partnerships with NHS organisations that use our products...

Injecting Stem Cells into the Heart Could Stop Chronic Chest Pain

July 10, 2011 8:33 pm | by Massachusetts Institute of Technology | News | Comments

Early research suggests that the treatment works by promoting blood vessel growth.

Stryker Announces Exclusive Collaboration With RegenLab

July 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 8, 2011 /- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's...

Generex Provides Preliminary Results of Generex Oral-lynâ„¢ Clinical Trials in Patients with Type 1 Diabetes and Patients with Impaired Glucose Tolerance

July 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass. and TORONTO, July 8, 2011 /- Generex Biotechnology Corporation (OTC Bulletin Board: GNBT ) ( ) today announced preliminary clinical results of two major trials using the Generex Oral-lyn™ formulation that will be used for registration and marketing....

Accuray's CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer

July 7, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., July 7, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced new clinical data highlighting the ability of its CyberKnife® Robotic Radiosurgery System and its TomoTherapy® Radiation Therapy System to treat a wide...

FDA Proposes New Policy for Some Diagnostic and Radiology Devices

July 7, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 7, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration issued a draft guidance today describing its intent to exercise enforcement discretion with respect to the premarket notification requirements for certain in vitro diagnostic and radiology...

Lupin Launches Additional Strengths of Generic Lotrel® Capsules

July 6, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, July 6, 2011 /- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules.  Commercial shipments of the product have already commenced....

Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brainâ„¢

July 5, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, July 5, 2011 /- NeuroSigma, a Los Angeles-based neuromodulation company, today announced that a recent Phase I clinical trial revealed that external Trigeminal Nerve Stimulation (eTNS™) increased regional cerebral blood flow in brain regions associated with depression...

Acute Coronary Syndrome (ACS) Drug Market

July 5, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 5, 2011 /- announces that a new market research report is available in its catalogue: Acute Coronary Syndrome (ACS) Drug Market ...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.